10/16
07:41 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
10/16
07:41 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) was downgraded by analysts at Wedbush from a "strong-buy" rating to a "hold" rating.
10/15
01:32 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock, down previously from $80.00.
10/14
01:44 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
10/14
01:44 pm
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at B. Riley. They now have a $60.00 price target on the stock, up previously from $45.00.
10/14
11:16 am
lbph
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
Low
Report
Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
10/14
11:12 am
lbph
Rating for LBPH
Low
Report
Rating for LBPH